Accelerate Diagnostics Inc Market cap
What is the Market cap of Accelerate Diagnostics Inc?
The Market cap of Accelerate Diagnostics Inc is $45.21M
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on NASDAQ compared to Accelerate Diagnostics Inc
What does Accelerate Diagnostics Inc do?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Companies with market cap similar to Accelerate Diagnostics Inc
- Dawson Geophysical has Market cap of $45.16M
- De Nora India has Market cap of $45.16M
- Chembond Chemicals has Market cap of $45.17M
- VirTra Inc has Market cap of $45.17M
- Eastwood Bio-Medical Canada has Market cap of $45.17M
- China Oil Gangran has Market cap of $45.18M
- Accelerate Diagnostics Inc has Market cap of $45.21M
- Medical Properties Trust has Market cap of $45.23M
- Suyog Telematics has Market cap of $45.28M
- Parker Drilling Co has Market cap of $45.28M
- Zinnwald Lithium Ls ,01 has Market cap of $45.29M
- Wai Chi has Market cap of $45.30M
- First Graphene has Market cap of $45.30M